The global forage feed market has been undergoing noteworthy development in the past few years. This can be accredited to the progression in farm animal production, upsurge in the global meat intake, and growing awareness regar…
BMI View: The removal of economic sanctions heralds an era of uncertainty for Iran's pharmaceutical
market. Underlying issues regarding the operating environment will prevent an immediate uptick in
multinational drugmaker interest; rather, this will be a gradual process. Nevertheless, there has been a
notable boost in international cooperation with European counterparts in particular over the past six
months. This will support the Iranian government's aim to attract greater direct investment from foreign
Headline Expenditure Projections
? Pharmaceuticals: IRR69.55trn (USD1.93bn) in 2015 to IRR79.49trn (USD1.99bn) in 2016; +14.3% in
local currency terms and +2.9% in US dollar terms. Forecast downgraded from previous quarter.
? Healthcare: IRR800.60trn (USD22.24bn) in 2015 to IRR900.81trn (USD22.52bn) in 2016; +12.5% in
local currency terms and +1.3% in US dollar terms. Forecast upgraded from previous quarter.